Dividend Assets Capital LLC cut its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 29.6% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 3,269 shares of the pharmacy operator’s stock after selling 1,375 shares during the period. Dividend Assets Capital LLC’s holdings in Walgreens Boots Alliance were worth $252,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Commonwealth Bank of Australia raised its position in shares of Walgreens Boots Alliance by 139.5% in the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after buying an additional 26,893 shares during the last quarter. IBM Retirement Fund raised its position in shares of Walgreens Boots Alliance by 88.1% in the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after buying an additional 10,729 shares during the last quarter. Andra AP fonden raised its position in shares of Walgreens Boots Alliance by 35.3% in the second quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock valued at $4,565,000 after buying an additional 15,200 shares during the last quarter. Schwab Charles Investment Management Inc. raised its position in shares of Walgreens Boots Alliance by 5.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after buying an additional 154,995 shares during the last quarter. Finally, Birinyi Associates Inc. raised its position in shares of Walgreens Boots Alliance by 9.0% in the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after buying an additional 750 shares during the last quarter. Institutional investors own 61.18% of the company’s stock.

A number of equities research analysts recently issued reports on WBA shares. Morgan Stanley lowered shares of Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and dropped their price objective for the company from $95.00 to $85.00 in a report on Friday, October 6th. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, November 10th. Robert W. Baird reissued an “outperform” rating and issued a $80.00 price objective (down previously from $90.00) on shares of Walgreens Boots Alliance in a report on Thursday, October 19th. They noted that the move was a valuation call. Citigroup dropped their price objective on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a report on Thursday, November 2nd. Finally, Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, October 17th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $86.89.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by corporate insiders.

Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $72.71 on Monday. The stock has a market cap of $72,543.55, a PE ratio of 19.24, a PEG ratio of 1.31 and a beta of 1.22. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $88.00. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.07 earnings per share. research analysts expect that Walgreens Boots Alliance Inc will post 5.54 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 annualized dividend and a dividend yield of 2.20%. Walgreens Boots Alliance’s dividend payout ratio is presently 42.33%.

Walgreens Boots Alliance announced that its Board of Directors has authorized a stock buyback plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

TRADEMARK VIOLATION NOTICE: This article was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://theolympiareport.com/2017/12/25/walgreens-boots-alliance-inc-wba-shares-sold-by-dividend-assets-capital-llc.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.